Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Childhood acute lymphoblastic leukemia: results of the Austrian Cooperative Study Group with the ALL A 84 protocol.

Medical and pediatric oncology - 1 Jan 1990

Gruemayer E R, Gadner H, Mutz I, Urban C, Ausserer B, Grienberger H, Juergenssen O, Koeller U, Mueller G, Panzer S

Abstract excerpt

We prospectively treated 127 children with ALL with a risk-adapted regimen. All patients received the identical induction-consolidation therapy. The early maintenance included intermediate dose methotrexate in patients with standard risk (n = 79) and medium risk (n = 39). In addition patients with high risk (n = 6) received high dose ARA-C followed by L-asparaginase. Intensification treatment and prophylactic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Child

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Infant

Share to Phenotype

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Prognosis

Share to Risk Factors

Source

Identifiers

PMID: 2403631
DOI: 10.1002/mpo.2950180103

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Childhood acute lymphoblastic leukemia: results of the Austrian Cooperative Study Group with the ALL A 84 protocol.PMID 2403631Read ↗

Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia.Semantic proximity Read ↗

Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia.Semantic proximity Read ↗

Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APLSemantic proximity Read ↗

Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 StudySemantic proximity Read ↗

Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - A multi-centric clinical study of GD-2008-ALL protocolSemantic proximity Read ↗

Changes in the Outcome of High-Risk Pediatric Patients with Acute Lymphoblastic Leukemia, from 2016 to 2024—Single Center, Real-Life ExperienceSemantic proximity Read ↗

[Risk-adapted therapy in acute myeloid leukemia].Semantic proximity Read ↗

Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.Semantic proximity Read ↗

CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy.Semantic proximity Read ↗

Acute lymphoblastic leukaemia in elderly patients: biological characteristics and therapeutic approaches.Semantic proximity Read ↗

Attempts to optimize postinduction treatment in childhood acute myeloid leukemia without core-binding factors: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).Semantic proximity Read ↗

Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia - a prospective study of 20 paediatric patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.